Journal Information
Vol. 6. Issue 1.
Pages 56-57 (January - February 2010)
Share
Share
Download PDF
More article options
Vol. 6. Issue 1.
Pages 56-57 (January - February 2010)
Full text access
Response to rituximab in a patient with Wegener's granulomatosis refractory to conventional therapies
Respuesta a rituximab en un paciente con granulomatosis de Wegener refractaria a terapia convencional
Visits
5066
Inmaculada Macías Fernández
Sección de Reumatología, Hospital Universitario Puerta del Mar, Cádiz, Spain
This item has received
Article information
Abstract
Bibliography
Download PDF
Statistics
Abstract

Male patient with a diagnosis of Wegener's granulomatosis associated to anti-proteinase 3 antibodies that improved initially to treatment with high dose glucocorticoids and cyclophosphamide but who relapsed, with a poor response to glucocorticoid treatment, cyclophosphamide, methotrexate and azathioprine. The patient received treatment with rituximab in 4 doses with clinical and radiographic improvement.

Keywords:
Wegener's granulomatosis
Refractory
Rituximab
Biological therapies
Resumen

Se presenta el caso de un paciente con granulomatosis de Wegener asociada a anticuerpos antiproteinasa 3 que tuvo mejoría inicial con dosis altas de glucocorticoides y ciclofosfamida, pero que posteriormente a una recaída no respondió a los mismos medicamentos, ni a metotrexate ni a zatioprina. Por tal motivo, recibió tratamiento con rituximab en 4 dosis, además de glucocorticoides, obteniendo mejoría del cuadro tanto clínica como radiográficamente.

Palabras clave:
Granulomatosis de Wegener
Refractario
Rituximab
Terapias biológicas
Full text is only aviable in PDF
References
[1.]
P. Seo, J.H. Stone.
Update on medium and small vessel vasculitides.
Arthritis Care Res, 53 (2005), pp. 93-99
[2.]
L. Guillevin, J.F. Cordier, F. Lhote, P. Cohen, B. Jarrousse, I. Royer, et al.
A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosis.
[3.]
R.W. Lee, D.P. D’Cruz.
Novel therapies for anti-neutrophil cytoplasmic antibody-associated vasculitis.
Drugs, 68 (2008), pp. 747-770
[4.]
K.R. Chen, J.A. Carlson.
Clinical approach to cutaneous vasculitis.
Am J Clin Dermatol, 9 (2008), pp. 71-92
[5.]
K.A. Keogh, S.R. Ytterberg, F.C. Fervenza, K.A. Carlson, D.R. Schroeder, U. Specks.
Rituximab for refractory Wegener's granulomatosis: report of a prospective, openlabel pilot trial.
Am J Respir Crit Care Med, 173 (2006), pp. 180-187
[6.]
R. Stasi, E. Stipa, G. Del Poeta, S. Amadori, A.C. Newland, D. Provan.
Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab.
Rheumatology, 45 (2006), pp. 1432-1436
[7.]
D. Sánchez Cano, J.L. Callejas Rubio, N. Ortego Centeno.
Effect of rituximab on refractory Wegener granulomatosis with predominant granulomatous disease.
J Clin Rheumatol, 14 (2008), pp. 92-93
[8.]
D. Wayne.
What place for the new biologics in the treatment of necrotising vasculitides.
Clin Exp Rheumatol, 24 (2006), pp. S1-S5
[9.]
P.M. Aries, B. Hellmich, J. Voswinkel, M. Both, B. Nölle, K. Holl-Ulrich, et al.
Lack of efficacy of rituximab in Wegener's granulomatosis with refractory granulomatous manifestations.
Ann Rheum Dis, 65 (2006), pp. 853-858
[10.]
B. Brihaye, A. Aouba, C. Pagnoux, P. Cohen, F. Lacassin, L. Guillevin.
Adjunction of rituximab to steroids and immunosuppressants for refractory/relapsing Wegener's granulomatosis: a study on 8 patients.
Clin Exp Rheumatol, 25 (2007), pp. 23-27
[11.]
R. Jones, C. Savage, C.A. Peh.
Rituximab: a novel remission induction agent in ANCA associated vasculitis. The design of an international, randomised trial (RITUXVAS).
J Am Soc Nephrol, 18 (2007), pp. 972A
Copyright © 2010. Sociedad Española de Reumatología and Colegio Mexicano de Reumatología
Download PDF
Idiomas
Reumatología Clínica (English Edition)
Article options
Tools
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?